up over 10% on no news, page-23

steve 10
maybe not as long as first planned- everything being fast tracked- red tape barriers broken esp in covid vacc
but vacc still way to far away- therapeutics the only bridging answer
recce looks to have a box seat as a therapeutic application
in that case we have an uncapped upside here
smart money on to that but cant extract much volume at every price point
my earlier expectations fir a july august mcap valuation now exceeded yet again
i didnt want to appear too way out there!
now easy see 100 m market cap next week with that modest value more aligned on even the lower value bio peers at stage 1 human trials
with the urgent unmet need expanding and recce 327 applications widening to 4 or possibly 5 fronts i expect reasonably this valuation to continue to accrete rapidly still
i an definitely not a seller despite i see posters saying they sold today post big cap raise returns since 26c
i doubt they will be able to reenter below those trader levels given the increasing demand for stock and most other holders looking to future large multiples here